OBJECTIVE: To assess the relationships of prenatal and childhood smoke exposure with specific neurodevelopmental and behavioral problems during early childhood. STUDY DESIGN: A subsample (n = 386) of mother-child dyads from the Newborn Epigenetic Study (NEST) prebirth cohort participated in the study. Cotinine concentrations were used to objectively measure prenatal and childhood smoke exposure when youth were aged 3-13 years. Multivariable regression models were used to estimate associations of prenatal and childhood cotinine concentrations with performance on the National Institutes of Health (NIH) Toolbox and attention-deficit/hyperactivity disorder and behavioral symptoms, measured using the Behavior Assessment System for Children, 2nd edition (BASC-2). RESULTS: After adjusting for confounders, childhood cotinine concentrations were associated with poorer cognitive performance on tasks measuring cognitive flexibility (B = -1.29; P = .03), episodic memory (B = -0.97; P = .02), receptive language development (B = -0.58; P = .01), and inhibitory control and attention (B = -1.59; P = .006). Although childhood cotinine concentration was associated with higher levels of attention problems (B = 0.83; P = .004) on the BASC-2, after adjustment for confounders, the association is nonsignificant. Although associations for maternal cotinine concentrations were null, an interaction was detected between prenatal and childhood cotinine concentrations on the NIH Toolbox Picture Vocabulary Task (P = .02). CONCLUSIONS: Our findings suggest that childhood tobacco smoke exposure may lead to poorer attention regulation and language acquisition, complex visual processing ability, and attention problems.
- MeSH
- hyperkinetická porucha * etiologie MeSH
- kognice MeSH
- kotinin MeSH
- lidé MeSH
- mladiství MeSH
- novorozenec MeSH
- předškolní dítě MeSH
- těhotenství MeSH
- znečištění tabákovým kouřem * škodlivé účinky MeSH
- zpožděný efekt prenatální expozice * MeSH
- Check Tag
- lidé MeSH
- mladiství MeSH
- novorozenec MeSH
- předškolní dítě MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- Research Support, U.S. Gov't, Non-P.H.S. MeSH
BACKGROUND: Selpercatinib, a highly selective, potent RET inhibitor, has shown efficacy in advanced RET-mutant medullary thyroid cancer in a phase 1-2 trial, but its efficacy as compared with approved multikinase inhibitors is unclear. METHODS: We conducted a phase 3, randomized trial comparing selpercatinib as first-line therapy with the physician's choice of cabozantinib or vandetanib (control group). Eligible patients had progressive disease documented within 14 months before enrollment. The primary end point in the protocol-specified interim efficacy analysis was progression-free survival, assessed by blinded independent central review. Crossover to selpercatinib was permitted among patients in the control group after disease progression. Treatment failure-free survival, assessed by blinded independent central review, was a secondary, alpha-controlled end point that was to be tested only if progression-free survival was significant. Among the other secondary end points were overall response and safety. RESULTS: A total of 291 patients underwent randomization. At a median follow-up of 12 months, median progression-free survival as assessed by blinded independent central review was not reached in the selpercatinib group and was 16.8 months (95% confidence interval [CI], 12.2 to 25.1) in the control group (hazard ratio for disease progression or death, 0.28; 95% CI, 0.16 to 0.48; P<0.001). Progression-free survival at 12 months was 86.8% (95% CI, 79.8 to 91.6) in the selpercatinib group and 65.7% (95% CI, 51.9 to 76.4) in the control group. Median treatment failure-free survival as assessed by blinded independent central review was not reached in the selpercatinib group and was 13.9 months in the control group (hazard ratio for disease progression, discontinuation due to treatment-related adverse events, or death, 0.25; 95% CI, 0.15 to 0.42; P<0.001). Treatment failure-free survival at 12 months was 86.2% (95% CI, 79.1 to 91.0) in the selpercatinib group and 62.1% (95% CI, 48.9 to 72.8) in the control group. The overall response was 69.4% (95% CI, 62.4 to 75.8) in the selpercatinib group and 38.8% (95% CI, 29.1 to 49.2) in the control group. Adverse events led to a dose reduction in 38.9% of the patients in the selpercatinib group, as compared with 77.3% in the control group, and to treatment discontinuation in 4.7% and 26.8%, respectively. CONCLUSIONS: Selpercatinib treatment resulted in superior progression-free survival and treatment failure-free survival as compared with cabozantinib or vandetanib in patients with RET-mutant medullary thyroid cancer. (Funded by Loxo Oncology, a subsidiary of Eli Lilly; LIBRETTO-531 ClinicalTrials.gov number, NCT04211337.).
- MeSH
- antitumorózní látky * škodlivé účinky terapeutické užití MeSH
- chinazoliny škodlivé účinky terapeutické užití MeSH
- lidé MeSH
- nádory štítné žlázy * farmakoterapie genetika MeSH
- piperidiny škodlivé účinky terapeutické užití MeSH
- progrese nemoci MeSH
- protoonkogenní proteiny c-ret genetika MeSH
- pyridiny * škodlivé účinky terapeutické užití MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky, fáze III MeSH
- randomizované kontrolované studie MeSH
- srovnávací studie MeSH
In Bacteria, chromosome replication starts at a single origin of replication and proceeds on both replichores. Due to its asymmetric nature, replication influences chromosome structure and gene organization, mutation rate, and expression. To date, little is known about the distribution of highly conserved genes over the bacterial chromosome. Here, we used a set of 101 fully sequenced Rhodobacteraceae representatives to analyze the relationship between conservation of genes within this family and their distance from the origin of replication. Twenty-two of the analyzed species had core genes clustered significantly closer to the origin of replication with representatives of the genus Celeribacter being the most apparent example. Interestingly, there were also eight species with the opposite organization. In particular, Rhodobaca barguzinensis and Loktanella vestfoldensis showed a significant increase of core genes with distance from the origin of replication. The uneven distribution of low-conserved regions is in particular pronounced for genomes in which the halves of one replichore differ in their conserved gene content. Phage integration and horizontal gene transfer partially explain the scattered nature of Rhodobacteraceae genomes. Our findings lay the foundation for a better understanding of bacterial genome evolution and the role of replication therein.
- MeSH
- Alzheimerova nemoc MeSH
- demence * farmakoterapie MeSH
- Ginkgo biloba * účinky léků MeSH
- klinická studie jako téma metody MeSH
- kognice účinky léků MeSH
- kognitivní dysfunkce * farmakoterapie MeSH
- rostlinné extrakty aplikace a dávkování terapeutické užití MeSH
- vaskulární demence MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- Publikační typ
- přehledy MeSH
Despite not being used for decades in most countries, DDT remains ubiquitous in soils due to its persistence and intense past usage. Because of this it is still a pollutant of high global concern. Assessing long term dissipation of DDT from this reservoir is fundamental to understand future environmental and human exposure. Despite a large research effort, key properties controlling fate in soil (in particular, the degradation half-life (τsoil)) are far from being fully quantified. This paper describes a case study in a large central European catchment where hundreds of measurements of p,p'-DDT concentrations in air, soil, river water and sediment are available for the last two decades. The goal was to deliver an integrated estimation of τsoil by constraining a state-of-the-art hydrobiogeochemical-multimedia fate model of the catchment against the full body of empirical data available for this area. The INCA-Contaminants model was used for this scope. Good predictive performance against an (external) dataset of water and sediment concentrations was achieved with partitioning properties taken from the literature and τsoil estimates obtained from forcing the model against empirical historical data of p,p'-DDT in the catchment multicompartments. This approach allowed estimation of p,p'-DDT degradation in soil after taking adequate consideration of losses due to runoff and volatilization. Estimated τsoil ranged over 3000-3800 days. Degradation was the most important loss process, accounting on a yearly basis for more than 90% of the total dissipation. The total dissipation flux from the catchment soils was one order of magnitude higher than the total current atmospheric input estimated from atmospheric concentrations, suggesting that the bulk of p,p'-DDT currently being remobilized or lost is essentially that accumulated over two decades ago.
- MeSH
- chemické látky znečišťující vodu analýza MeSH
- chemické modely MeSH
- DDT analýza MeSH
- geologické sedimenty chemie MeSH
- hydrologie MeSH
- látky znečišťující půdu analýza MeSH
- látky znečišťující vzduch analýza MeSH
- lidé MeSH
- monitorování životního prostředí metody MeSH
- půda chemie MeSH
- řeky chemie MeSH
- vystavení vlivu životního prostředí MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
